Switch to: References

Add citations

You must login to add citations.
  1. Manufacturing Life, What Life? Ethical Debates Around Biobanks and Social Robots.Núria Vallès-Peris, Violeta Argudo-Portal & Miquel Domènech - 2022 - NanoEthics 16 (1):21-34.
    In this paper, we explore how the definition of life takes on an essential character in the ethical debates around health technologies, with life thus being manufactured in the tensions and conflicts around the use of such artefacts and devices. We introduce concepts from science and technology studies (STS) to approach bioethics, overcoming the dualistic conception that separates the natural and the technological and questioning the dominant rationality that divides life into dualities. Drawing on two research projects in which we (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • A Journey Through Global Bioethics.Kristina Orfali - 2019 - Journal of Bioethical Inquiry 16 (3):305-308.
    Download  
     
    Export citation  
     
    Bookmark  
  • Mapping Bioethics in Latin America: History, Theoretical Models, and Scientific Output.Lucas F. Garcia, Marcia S. Fernandes, Jonathan D. Moreno & Jose R. Goldim - 2019 - Journal of Bioethical Inquiry 16 (3):323-331.
    Objective: To present a narrative review of the history of bioethics in Latin America and of scientific output in this interdisciplinary field. Methods: This was a mixed-methods study. Results: A total of 1458 records were retrieved, of which 1167 met the inclusion criteria. According to the Web of Science classification, the predominant topics of study were medical ethics, social sciences and medicine, and environmental and public health topics. Four themes of bioethics output in the Latin American literature have emerged: issues (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Bioethics of intervention and the case of drugs Bevacizumab and Ranibizumab for retinal diseases.Flávio R. L. Paranhos - 2016 - Revista Iberoamericana de Bioética 2.
    From the year 2000, on a class of biological drugs, the anti-VEGF proved to be quite effective in the treatment of retinal diseases, which have in its pathophysiological mechanism an important vascular proliferation component that can lead to blindness. Two of these drugs, bevacizumab and ranibizumab, are quite similar and have the same efficacy and safety. They were developed by the same laboratory and are commercialized by two major pharmaceutical companies through an agreement made between them. However, there is a (...)
    Download  
     
    Export citation  
     
    Bookmark